Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Shanghai Seme Cell Technology Co. Ltd. currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners, indicating that the workload is not spread among a unique individual for every case. The prosecution activity is further divided between 2 distinct art units, which suggests the applications fall into multiple technical classifications within the broader biotechnology sector.
The busiest examiner for this portfolio is BOECKELMAN, JACOB A, who is responsible for 2 pending office actions. For practitioners, this means that BOECKELMAN, JACOB A oversees 2 of the 3 pending office actions, making his examination style a primary factor in the company's immediate prosecution outcomes. The use of 2 distinct art units implies that while the examiner workload is concentrated, the technical focus of the applications is split across different specialized groups at the USPTO.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 2 | 35.2% | +45.6% |
| UNDERDAHL, THANE E | 1 | 58.8% | +50.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252254 | THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS | UNDERDAHL, THANE E | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17635524 | FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF FOR GENERATING DROPLET ARRAY ON MICROFLUIDIC CHIP | BOECKELMAN, JACOB A | 25d overdue |
| 18039639 | THERAPEUTIC USE OF CELL-FREE FAT EXTRACT FOR OSTEOPOROSIS | BOECKELMAN, JACOB A | 24d overdue |
| 18252254 | THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS | UNDERDAHL, THANE E | 14d |
| Art Unit | Apps |
|---|---|
| 1655 | 2 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039639 | THERAPEUTIC USE OF CELL-FREE FAT EXTRACT FOR OSTEOPOROSIS | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | 24d overdue | Pending | May 31, 2023 |
| 18252254 | THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS | UNDERDAHL, THANE E | 1699 | §102§103§112 | Final Rejection | 14d | Pending | May 09, 2023 |
| 17635524 | FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF FOR GENERATING DROPLET ARRAY ON MICROFLUIDIC CHIP | BOECKELMAN, JACOB A | 1655 | §103Other | Final Rejection | 25d overdue | Pending | Feb 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial